Advertisement

Toxicology of Glucosidase Inhibitors

  • E. M. Bomhard
Part of the Handbook of Experimental Pharmacology book series (HEP, volume 119)

Abstract

A large number of toxicity studies have been performed on the general and reproduction toxicology, genotoxicity and carcinogenicity of acarbose. Besides the usual guideline studies required by the international authorities for registration, several special studies have also been initiated to clarify the effects that were observed in the original long-term study of acarbose in rats and which were of questionable relevance for the clinical situation. Some of these results have been published in previous articles (Schlüter1982a, 1988).

Keywords

Dose Level Leydig Cell Body Weight Gain Leydig Cell Tumour Carcinogenicity Study 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Ahr HJ, Boberg M, Krause HP, Maul W, Müller FO, Ploschke HJ, Weber H, Wünsche C (1989) Pharmacokinetics of acarbose. Part I: absorption, concentration in plasma, metabolism and excretion after single administration of [14C]acarbose to rats, dogs and man. Drug Res 39:1254–1260Google Scholar
  2. Atkinson JE, Daly IW, Saulog TM, Suzuki T (1991a) One-year oral gavage toxicity study of AO-128 in rats. Jpn Pharmacol Ther 19:233–260Google Scholar
  3. Atkinson JE, Daly IW, Saulog TM, Fukuda R, Tanakamaru Z, Nonoyama T (1991b) Oncogenicity study of AO-128 in mice. Jpn Pharmacol Ther 19:131–142Google Scholar
  4. Atkinson JE, Daly IW, Saulog TM, Suzuki T (1991c) One-year oral toxicity study of AO-128 in beagle dogs. Jpn Pharmacol Ther 19:261–282Google Scholar
  5. Bär A (1992) Significance of leydig cell neoplasia in rats fed lactitol or lactose. J Am Coll Toxicol 11:189–207CrossRefGoogle Scholar
  6. Balfour JA, McTavish D (1993) Acarbose. An update of its pharmacology and therapeutic use in diabetes mellitus. Drugs 46:1025–1054PubMedCrossRefGoogle Scholar
  7. Bomhard E (1992) Frequency of spontaneous tumours in wistar rats in 30-month studies. Exp Toxicol Pathol 44:381–392PubMedCrossRefGoogle Scholar
  8. Bomhard E, Karbe E, Löser E (1986) Spontaneous tumours of 2000 wistar TNO/W 70 rats in two-year carcinogenicity studies. J Environ Pathol Toxicol Oncol 7:35–52PubMedGoogle Scholar
  9. Bomhard E, Rinke M (1994) Frequency of spontaneous tumours in wistar rats in 2-year studies. Exp Toxicol Pathol 46:17–29PubMedCrossRefGoogle Scholar
  10. De Groot AP (1987) Biological effects of low digestibility carbohydrates. In: Leegwater DC, Feron VJ, Hermus RJJ (eds) Low digestibility carbohydrates. Pudoc, Wageningen, pp 12–22Google Scholar
  11. Doherty NS, Beaver TH (1990) Comparison of the anaphylactoid response induced in rats by castanospermine and dextran. Int Arch Allergy Appl Immunol 93:19–25PubMedCrossRefGoogle Scholar
  12. Fafournoux P, Rémésy C, Demigné C (1993) Control of alanine metabolism in rat liver by transport processes or cellular metabolism. Biochem J 210:645–652Google Scholar
  13. Gardner KD (1961) The effect of pH on the filtration, reabsorption and excretion of protein by the rat kidney. J Clin Invest 40:525–535PubMedCrossRefGoogle Scholar
  14. Geddes R, Taylor JA (1985) Lysosomal glycogen storage induced by acarbose, a 1,4-alpha-glucosidase inhibitor. Biochem J 228:319–324PubMedGoogle Scholar
  15. Gross L (1988) Inhibition of the development of tumours or leukemia in mice and rats after reduction of food intake. Cancer 62:1463–1465PubMedCrossRefGoogle Scholar
  16. Haase P (1978) Parathyroid stimulation in phosphate induced nephrocalcinosis. J Anat 125:299–311PubMedGoogle Scholar
  17. Heard CR, Frangi SM, Wright PM, Mccartney PR (1977) Biochemical characteristics of different forms of protein-energy malnutrition: an experimental model using young rats. Br J Nutr 37:1–21PubMedCrossRefGoogle Scholar
  18. Kamikawa T, Yamashita S, Kobayashi N, Minaga T (1989a) Acute toxicity study of acarbose with a single oral or intravenous administration in rats (in Japanese). Clin Res 23 (12):7–10Google Scholar
  19. Kamikawa T, Yamashita S, Kobayashi N, Minaga T (1989b) Toxicity study in rats treated orally with acarbose for 13 weeks (in Japanese). Clin Res 23(12):11–34Google Scholar
  20. Keenan K, Smith P, Ballam G, Soper K, Bokelman D (1992) The effect of diet and dietary optimisation (caloric restriction) on survival in carcinogenicity studies — an industry viewpoint. In: McAuslane JAN, Lumley CE, Walker SR (eds) The carcinogenicity debate. Quay Publishing, pp 77–102Google Scholar
  21. Konishi Y, Hata Y, Fujimori K (1989) Formation of glycogenosomes in rat liver induced by injection of acarbose, an α-glucosidase inhibitor. Acta Histochem Cytochem 22:227–231CrossRefGoogle Scholar
  22. Konishi Y, Okawa Y, Hosokawa S, Fujimori K, Fuwa H (1990) Lysosomal glycogen accumulation in rat liver and its in vivo kinetics after a single intraperitoneal injection of acarbose, an α-glucosidase inhibitor. J Biochem 107:197–201PubMedGoogle Scholar
  23. Lembcke B, Löser C, Frölsch UR, Wöhler J, Creutzfeld W (1987) Adaptive responses to pharmacological inhibition of small intestinal α-glucosidase in the rat. Gut 28:181–187PubMedCrossRefGoogle Scholar
  24. Lembcke B, Lamberts R, Wöhler J, Creutzfeld W (1991) Lysosomal storage of glycogen as a sequel of a α-glucosidase inhibition by the absorbed deoxyno-jirimycin derivative emiglitate (Bay o 1248). Res Exp Med (Berl) 191:389–404CrossRefGoogle Scholar
  25. Lina B, Dreef-Van Der Meulen HC, De Groot AP, Suzuki T (1991) Subchronic (90-day) oral toxicity study with AO-128 in rats. Jpn Pharmacol Ther 19:181–208Google Scholar
  26. Lord GH, Newberne PM (1990) Renal mineralization — A ubiquitous lesion in chronic rat studies. Food Chem Toxicol 28:449–455PubMedCrossRefGoogle Scholar
  27. Lüllmann-Rauch R (1981) Lysosomal storage glycogen mimicking the cytological picture of Pompe’s disease as induced in rats by injection of an α-glucosidase inhibitor. I. Alterations in liver. Virchows Arch 38:89–100CrossRefGoogle Scholar
  28. Lüllmann-Rauch R (1982) Lysosomal glycogen storage mimicking the cytological picture of Pompe’s disease as induced in rats by injection of an α-glucosidase inhibitor. II. Alterations in kidney, adrenal gland, spleen and soleus muscle. Virchows Arch 39:187–202CrossRefGoogle Scholar
  29. Macgregor JT, Caldwell K, Crawford L (1989) Biological effects of plant secondary metabolites in mammals. Fedrip Database; National Technical Information Service (NTIS). Western Regional Res Center/Toxicology & Biological Eval/Research Unit. Albany, California 94710Google Scholar
  30. Maeshiba Y, Kondo, Kobayashi T, Tanayama K (1991) Metabolic fate of AO-128, a new α-glucosidase inhibitor, in rats and dogs (in Japanese). Jpn Pharmacol Ther 19:247–257Google Scholar
  31. Morseth SL, Nakatsu T (1991a) Reproduction study in rats with AO-128. Jpn Pharmacol Ther 19:29–44Google Scholar
  32. Morseth SL, Nakatsu T (1991b) Teratological study in rats with AO-128. Jpn Pharmacol Ther 19:45–67Google Scholar
  33. Morseth SL, Nakatsu T (1991c) Perinatal and postnatal study in rats with AO-128. Jpn Pharmacol Ther 19:79–100Google Scholar
  34. Morseth SL, Nakatsu T (1991d) Teratological study in rabbits with AO-128. Jpn Pharmacol Ther 19:69–78Google Scholar
  35. Nakai Y, Doi T, Inoue S (1991) Antigenicity of AO-128 in guinea pigs and mice (in Japanese). Jpn Pharmacol Ther 19:101–105Google Scholar
  36. Nonoyama T, Imai R, Tensha S, Nagai H, Sakura Y, Wada T (1991) Onocogenncity study of AO-128 in rats (in Japanese). Jpn Pharmacol Ther 19:119–129Google Scholar
  37. Otto K (1965) Alanin-transaminase und gluconeogenese. Hoppe-Seylers Zschr Physiol Chem 341:99–104CrossRefGoogle Scholar
  38. Pickering RG, Pickering CE (1984) The effect of diet on the incidence of pituitary tumours in female wistar rats. Lab Anim 18:298–314PubMedCrossRefGoogle Scholar
  39. Rhinehart BL, Begovic ME, Robinson KM (1991) Quantitative relationship of lysosomal glycogen accumulation to lysosomal α-glucosidase inhibition in cas-tanospermine treated rats. Biochem Pharmacol 41:223–228PubMedCrossRefGoogle Scholar
  40. Roe FJC, Bär A (1985) Enzootic and epizootic adrenal medullary proliferative disease of rats: influence of dietary factors which affect calcium absorption. Hum Toxicol 4:27–52PubMedCrossRefGoogle Scholar
  41. Rowsell EV, Snell K, Carnie JA, Al-Tai AH (1969) Liver L-alanine-glyoxylate and L-serine-pyruvate aminotransferase activities: an apparent association with gluconeogenesis. Biochem J 115:1071–1073PubMedGoogle Scholar
  42. Rowsell EV, Al-Tai AH, Carnie JA (1973) Increased liver L-serine-pyruvate aminotransferase activity under gluconeogenic consitions. Biochem J 134:349–351PubMedGoogle Scholar
  43. Sakamoto Y, Fujikawa K, Nakamura M, Hitotumachi S (1991) Mutagenicity studies of AO-128 (in Japanese). Jpn Pharmacol Ther 19:107–117Google Scholar
  44. Saul R, Ghidoni JJ, Molyneux RJ, Elbein AD (1985) Castanospermine inhibits α-glucosidase activities and alters glycogen distribution in animals. Proc Natl Acad Sci 82:93–97PubMedCrossRefGoogle Scholar
  45. Saxton JA, Sperling GA, Barnes LL, Mccay CM (1948) The influence of nutrition upon the incidence of spontaneous tumours of the albino rat. Acta Unio Int Cancrum 6:423–431Google Scholar
  46. Schlüter G (1982) Toxicology of acarbose. In: Creutzfeld W (ed) Proceedings of 1. international symposium of acarbose. Excerpta Medica Amsterdam 1982, International Congress Series 594, pp 49–54Google Scholar
  47. Schlüter G (1988) Toxicology of acarbose, with special reference to long-term carcinogenicity studies. In: Creutzfeld W (ed) Acarbose for the treatment of diabetes mellitus. Springer, Berlin, pp 5–14CrossRefGoogle Scholar
  48. Sinkeidam EJ, Woutersen RA, Hollanders VMH, Til HP, Van Garderen-Hoetmer A, Bär A (1992) Subchronic and chronic toxicity/carcinogenicity feeding studies with lactitol in rats. J Am Coll Toxicol 11:165–188CrossRefGoogle Scholar
  49. Sunkara PS, Bowlin TL, Liu PS, Sjoerdsma A (1987) Antiretroviral activity of castanospermine and deoxynojirimycin, specific inhibitors of glycoprotein processing. Biochem Biophys Res Commun 148:206–210PubMedCrossRefGoogle Scholar
  50. Suzuki T, Nagayabu T, Sato S, Abe T, Miyajima H, Matsuo T (1991) Effect of carbohydrates on oral toxicity of AO-128 in rats (in Japanese). Jpn Pharmacol Ther 19:13–19Google Scholar
  51. Til HP, Kuper CF, Falke He, De Groot AP, Suzuki T (1991) Subchronic (90-Day) oral toxicity study with AO-128 in dogs. Jpn Pharmacol Thet 19:209–231Google Scholar
  52. Tucker MJ (1979) The effect of long-term food restriction on tumours in rodents. Int J Cancer 23:803–807PubMedCrossRefGoogle Scholar
  53. Yeung D, Oliver IT (1967) Gluconeogenesis from amino acids in neonatal rat liver. Biochem J 103:744–748PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1996

Authors and Affiliations

  • E. M. Bomhard

There are no affiliations available

Personalised recommendations